# OnCo record wayshine-biopharm (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/wayshine-biopharm/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "wayshine-biopharm" ;
  schema:name "Wayshine Biopharm"@en ;
  schema:alternateName "Wayshine Biopharm, Inc."@en ;
  schema:description "Wayshine Biopharm is a China-based biotechnology company that leads 3 cancer trials in OnCo, testing the brain-penetrant EGFR inhibitor WSD0922-FU in non-small-cell lung cancer and small-cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/wayshine-biopharm/>, <http://www.wayshinebiopharm.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <http://www.wayshinebiopharm.com>, <https://clinicaltrials.gov/search?lead=Wayshine%20Biopharm%2C%20Inc.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:drugs <https://onco.cc/drugs/osimertinib/> ;
  onco:trials <https://onco.cc/trials/nct06631989/>, <https://onco.cc/trials/nct06868485/>, <https://onco.cc/trials/nct07206498/> .